相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trends in Neutropenia-Related Inpatient Events
Chris M. Kozma et al.
JOURNAL OF ONCOLOGY PRACTICE (2012)
Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study
Hiangkiat Tan et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Risk of Hospitalization for Neutropenic Complications of Chemotherapy in Patients With Primary Solid Tumors Receiving Pegfilgrastim or Filgrastim Prophylaxis: A Retrospective Cohort Study
Derek Weycker et al.
CLINICAL THERAPEUTICS (2009)
Cost of neutropenic complications of chemotherapy
D. Weycker et al.
ANNALS OF ONCOLOGY (2008)
2006 update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?
D Weycker et al.
ANNALS OF PHARMACOTHERAPY (2006)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Risk models for predicting chemotherapy-induced neutropenia
GH Lyman et al.
ONCOLOGIST (2005)
Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy
V Caggiano et al.
CANCER (2005)
Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management
J Crawford et al.
CANCER (2004)
Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma
A Grigg et al.
LEUKEMIA & LYMPHOMA (2003)
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma
JM Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
MD Green et al.
ANNALS OF ONCOLOGY (2003)
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer
FA Holmes et al.
ANNALS OF ONCOLOGY (2002)
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer
FA Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Filgrastim in patients with neutropenia - Potential effects on quality of life
GH Lyman et al.
DRUGS (2002)
分享论文
